- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04712045
Rational Use of Personal Protective Equipment During COVID-19 Pandemic (RUPERT)
January 13, 2021 updated by: ProfessorPeterMcculloch, University of Oxford
Rational Use of Personal Protective Equipment: a Randomised Trial and Quality Improvement Intervention During COVID-19 Pandemic
This study aims to improve the personal protective equipment (PPE) used while treating patients with COVID-19, to protect staff and avoid cross-infection of patients.
Protecting staff from infection during the Covid pandemic is critical to maintaining health services.
Mistakes in using protective equipment (PPE) are the commonest avoidable factor in staff becoming infected at work.
Recently, intensive care doctors have also reported an increase in the spread of dangerous multi-resistant bacteria between patients, which appears likely to be transmitted between patients by Level 2 PPE worn by staff (specifically gown sleeves).
This study therefore seeks to develop and test a new protocol to decrease cross-infection risks whilst using Level 2 PPE.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
67
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oxfordshire
-
Oxford, Oxfordshire, United Kingdom, OX3 9DU
- Professor Peter McCulloch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- NHS staff and works in the Adult Intensive Care Unit, Neuro Intensive Care Unit or Cardio-thoracic Intensive Care Unit
- Trained in the correct use of Level 2 PPE according to current guidance
- Trained in ICU COVID19 Intubation and Proning protocols
- Willing and able to give informed consent for participation in the study.
Exclusion Criteria:
1. taking any medication which can cause photosensitivity reactions in the preceding 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: New PPE
Use of Short sleeve gown and single pair of gloves
|
The use of a new protocol of level 2 PPE which involves wearing a short-sleeve gown and a single pair of gloves
|
|
Active Comparator: Old PPE
Use of Long sleeve gown and double pairs of gloves
|
The use of a standard protocol of level 2 PPE which involves wearing a long-sleeve gown and double pairs of gloves
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of participants and simulated patients with contamination as assessed by ultraviolet light
Time Frame: immediately after simulations
|
The primary outcome of this study is the proportion of participants and simulated patients who were contaminated with fluorescent powder as examined under a UV light, using a response of "YES" or "NO", when participants wore new (experimental) Level 2 PPE in comparison to the standard (control) Level 2 PPE
|
immediately after simulations
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participants' perception of personal comfort and safety and safety of the patients as assessed through structured questionnaire
Time Frame: immediately before simulations and immediately after simulations
|
We will measure the participants' perception of personal comfort and safety and the safety of the patient when wearing experimental versus control Level 2 PPE, during simulation tasks, using a 10 point Likert scale response to a structured questionnaire
|
immediately before simulations and immediately after simulations
|
|
changes in participants perception of personal comfort and safety and safety of patients as assessed through a semi-structured questionnaire
Time Frame: immediately before training, immediately after training and immediately after simulation
|
We will measure changes in participants perception of their personal comfort and safety and the safety of patients when wearing each type of PPE using a semi-structured interview (a) before the PPE training, (b) after the PPE training, and (c) after the simulation training exercises.
|
immediately before training, immediately after training and immediately after simulation
|
|
The difference in the area of contamination between New and Standard PPE as analyzed through python script
Time Frame: immediately after simulations
|
we will perform a quantitative analysis of the area of contamination of participants and simulated patients and assess the difference between when participants wore new (experimental) Level 2 PPE and the standard (control) Level 2 PPE, using pre-coded functions with python script.
|
immediately after simulations
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Peter McCulloch, University of Oxford
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2020
Primary Completion (Actual)
December 12, 2020
Study Completion (Actual)
December 12, 2020
Study Registration Dates
First Submitted
January 11, 2021
First Submitted That Met QC Criteria
January 13, 2021
First Posted (Actual)
January 15, 2021
Study Record Updates
Last Update Posted (Actual)
January 15, 2021
Last Update Submitted That Met QC Criteria
January 13, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRAS287865
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
-
Erasmus Medical CenterUniversity Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaboratorsRecruiting
Clinical Trials on New PPE
-
Institute of Mountain Emergency MedicineCompletedCardiopulmonary Resuscitation | Personal Protective EquipmentItaly
-
University Health Network, TorontoUnknown
-
Indonesia UniversityCompleted
-
University of Campinas, BrazilNot yet recruitingPersonal Protective Equipment
-
Roman SýkoraNot yet recruitingCommunication | Safety Issues | Cardiopulmonary Arrest
-
Hospital Italiano de Buenos AiresCompletedPersonal Protective Equipment | Self ContaminationArgentina
-
United States Department of DefenseMinneapolis Veterans Affairs Medical Center; University of Minnesota; VA Palo... and other collaboratorsRecruitingPost Traumatic Stress DisorderUnited States
-
Vanderbilt UniversityAmerican Psychological FoundationCompletedBehavioral Symptoms | Depressive Disorder | Depression | Mood Disorders | Anhedonia | Stress | Mental Disorder | Mood DisturbanceUnited States
-
Medical University of GrazCompletedPersonal Protective Equipment | Heat StressAustria
-
National Taiwan University HospitalCompletedThoracic SurgeryTaiwan